Literature DB >> 19631363

Increase in proinflammatory cytokines in peripheral blood without haemostatic changes after LPS inhalation.

Marc Fouassier1, Bertrand Souweine, Anne-Françoise Sapin, Afshin Hashemzadeh, Alain Marquès-Verdier, Denis Caillaud.   

Abstract

INTRODUCTION: Bronchoalveolar fibrin deposition is a characteristic of various lung disorders including acute lung injury, acute respiratory distress syndrome and sepsis. It is secondary to the activation of coagulation and inhibition of fibrinolysis in the alveolar space, and can be stimulated by lipopolysaccharide (LPS) inhalation. The aim of this study was to determine the relation between compartmental stress in the lung and systemic response after LPS inhalation by measuring haemostatic parameters. PATIENTS AND METHODS: 12 healthy subjects underwent a bronchial challenge test with LPS; sequential dosages were performed for 5 biological markers (Interleukin-6 (IL-6), C-Reactive Protein (CRP), Prothrombin Fragments 1 and 2 (F 1+2), cortisol and Plasminogen Activator Inhibitor 1 (PAI-1) before endotoxin inhalation and 2, 4, 6, 8 and 24 hours afterwards.
RESULTS: IL-6 and CRP levels in the peripheral blood were higher after LPS inhalation; there was no activation of coagulation and no increase in PAI-1 level.
CONCLUSION: This study confirms that despite systemic release of proinflammatory cytokines, LPS inhalation does not induce systemic haemostatic response to LPS challenge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631363     DOI: 10.1016/j.thromres.2009.06.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Direct factor Xa inhibition attenuates acute lung injury progression via modulation of the PAR-2/NF-κB signaling pathway.

Authors:  Meng Shi; Linlin Wang; Jian Zhou; Shimeng Ji; Ningfang Wang; Lin Tong; Jing Bi; Yuanlin Song; Jie Hu; Xiaofeng Chen
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.

Authors:  Vandana Gupta; Antonia Banyard; Aoibheann Mullan; Srividya Sriskantharajah; Thomas Southworth; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.